32
(MedPage Today) — Memantine hydrochloride, a noncompetitive NMDA receptor antagonist, may help improve social impairment in a specific subset of youth with autism spectrum disorder (ASD), a small trial suggested.
Nine of 16 youth (56.2%) treated…